No Data
Express News | Sangamo Therapeutics Inc : Jefferies Cuts Target Price to $7 From $8
Sangamo Therapeutics, Inc. (SGMO) Q3 2024 Earnings Call Transcript Summary
Express News | Sangamo Therapeutics Files for Mixed Shelf Offering of up to $500 Mln- SEC Filing
Sangamo Therapeutics (SGMO) Tops Q3 Earnings and Revenue Estimates
Sangamo Therapeutics | 10-Q: Quarterly report
Sangamo Therapeutics GAAP EPS of $0.04 Beats by $0.08, Revenue of $49.41M Beats by $24.34M
Kaibu Wang : What will cause after
Jaguar8 OP Kaibu Wang : It’s only a prospectus. They may sell common stocks from time to time once registration becomes effective. It means just be cautious
Kaibu Wang Jaguar8 OP : Thanks man